CHLOROPHYLLIPT

INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT CHLOROPHYLLIPT

Composition:

Active ingredient: 1 ml of solution contains chlorophyllipt extract, thick (10.76:1) (extractant ethanol 93%) - 20 mg;

Excipient: corn oil.

Pharmaceutical form. Oil solution.

Main physicochemical properties: dark green oily liquid.

Pharmacotherapeutic group. Antiseptics and disinfectants.

ATC code D08AX.

Pharmacological properties.

Pharmacodynamics.

The medicinal product is a mixture of chlorophylls from eucalyptus leaves. The medicinal product has antibacterial (bacteriostatic and bactericidal) activity against staphylococci, as well as antiseptic and anti-inflammatory activity.

Pharmacokinetics.

Not studied.

Clinical characteristics.

Indications.

Treatment of diseases caused by antibiotic-resistant staphylococci: cervical erosion, burns, trophic ulcers.

Contraindications.

Hypersensitivity to the components of the drug.

Interaction with other medicinal products and other forms of interactions.

Enhances the effect of antiseptic agents.

Instructions for use.

Consult a physician before starting use.

After the first application, a pause of 6–8 hours should be made. Course treatment with the drug is possible only after confirming the absence of an allergic reaction to the thick chlorophyllipt extract (possible symptoms include mucosal swelling, hyperemia at the application site, itching, rashes). If any of the above symptoms occur, discontinue use of the drug and consult a physician.

Use during pregnancy or breastfeeding.

The efficacy and safety of using the medicinal product during pregnancy or breastfeeding have not been studied; therefore, the drug should not be used in these patient categories.

Ability to influence reaction rate while driving or operating machinery.

No influence.

Method of administration and dosage.

The medicinal product is intended for topical use, applied to affected areas using a tampon. The duration of applications and treatment course is determined individually by a physician.

When treating cervical erosion, previously dry all vaginal folds and the vaginal portion of the cervix with tampons; apply the preparation to the cervical canal. Leave a tampon moistened with the preparation on the cervix for 15–20 minutes. Perform the procedure once daily for 10 days. If epithelialization of the erosion is incomplete, the treatment course should be repeated.

Children. There is no experience with the use of the drug in children.

Overdose.

An overdose may lead to an increase in adverse reactions.

Side effects.

Immune system side effects: allergic reactions are possible during the use of the drug, including mucosal swelling, hyperemia at the application site, itching, rash.

Shelf life. 2 years.

Storage conditions. Store in the original packaging at a temperature not exceeding 25 °C.

Keep out of reach of children.

Packaging. 20 ml in a bottle in a box.

Availability. Over-the-counter (without prescription).

Manufacturer.

Limited Liability Company "Experimental Plant "GNCLS".

LIMITED LIABILITY COMPANY "CORPORATION "ZDOROVIYA".

Manufacturer's address and location of business activities.

Ukraine, 61057, Kharkiv region, city of Kharkiv, Vorobiova Street, building 8.

(Limited Liability Company "Experimental Plant "GNCLS")

Ukraine, 61013, Kharkiv region, city of Kharkiv, Shevchenka Street, building 22.

(LIMITED LIABILITY COMPANY "CORPORATION "ZDOROVIYA")